AI-based drug developer Bullfrog files for proposed $8M IPO
seekingalpha.com
economics
2022-10-21 00:07:03

DariaRen AI-based drug developer Bullfrog AI (BFAI) has filed for a propose $8M initial public offering. The Maryland-based biotech said in a filing that it is looking at offering 1.3M units at the assumed priced of $6.375 per unit. Each unit would consist of one share plus one warrant to buy one share. Underwriters would be granted a 45-day option to buy up to 198K additional shares and/or warrants at the IPO price. Wallachbeth Capital and Viewtrade Securities are serving as lead bookrunners. The company hopes to list its shares on Nasdaq under the symbol BFAI.
